Y. Geng and P. Libby, Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme, Am J Pathol, vol.147, pp.251-266, 1995.

D. Han, C. Haudenschild, M. Hong, B. Tinkle, M. Leon et al., Evidence for apoptosis in human atherogenesis and in a rat vascular injury model, Am J Pathol, vol.147, pp.267-277, 1995.

G. Bauriedel, R. Hutter, U. Welsch, R. Bach, H. Sievert et al., Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability, Cardiovascular Research, vol.41, issue.2, pp.480-488, 1999.
DOI : 10.1016/S0008-6363(98)00318-6

K. Lindstedt, M. Leskinen, and P. Kovanen, Proteolysis of the Pericellular Matrix: A Novel Element Determining Cell Survival and Death in the Pathogenesis of Plaque Erosion and Rupture, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.8, pp.1-9, 2004.
DOI : 10.1161/01.ATV.0000135322.78008.55

A. Garcia-touchard, T. Henry, G. Sangiorgi, L. Spagnoli, A. Mauriello et al., Extracellular Proteases in Atherosclerosis and Restenosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.6, pp.1119-1127, 2005.
DOI : 10.1161/01.ATV.0000164311.48592.da

X. Houard, C. Monnot, V. Dive, P. Corvol, and M. Pagano, Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin, Journal of Cellular Biochemistry, vol.19, issue.6, pp.1188-1201, 2003.
DOI : 10.1002/jcb.10460

J. Davis, M. Wagner, W. Zhang, F. Xu, and W. Van-nostrand, Amyloid ??-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle Cells, Journal of Biological Chemistry, vol.278, issue.21, pp.19054-19061, 2003.
DOI : 10.1074/jbc.M301398200

P. Raghunath, J. Tomaszewski, S. Brady, R. Caron, S. Okada et al., Plasminogen Activator System in Human Coronary Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.15, issue.9, pp.1432-1443, 1995.
DOI : 10.1161/01.ATV.15.9.1432

V. Fontaine, M. Jacob, X. Houard, P. Rossignol, D. Plissonnier et al., Involvement of the Mural Thrombus as a Site of Protease Release and Activation in Human Aortic Aneurysms, The American Journal of Pathology, vol.161, issue.5, pp.1701-1710, 2002.
DOI : 10.1016/S0002-9440(10)64447-1

A. Stoop, F. Lupu, and H. Pannekoek, Colocalization of Thrombin, PAI-1, and Vitronectin in the Atherosclerotic Vessel Wall : A Potential Regulatory Mechanism of Thrombin Activity by PAI-1/Vitronectin Complexes, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.4, pp.1143-1149, 2000.
DOI : 10.1161/01.ATV.20.4.1143

D. Grainger, P. Kemp, A. Liu, R. Lawn, and J. Metcalfe, Activation of transforming growth factor-?? is inhibited in transgenic apolipoprotein(a) mice, Nature, vol.370, issue.6489, pp.460-462, 1994.
DOI : 10.1038/370460a0

A. Bonnefoy and C. Legrand, Proteolysis of Subendothelial Adhesive Glycoproteins (Fibronectin, Thrombospondin, and von Willebrand Factor) by Plasmin, Leukocyte Cathepsin G, and Elastase, Thrombosis Research, vol.98, issue.4, pp.323-332, 2000.
DOI : 10.1016/S0049-3848(99)00242-X

L. Liotta, R. Goldfarb, and V. Terranova, Cleavage of laminin by thrombin and plasmin: Alpha thrombin selectively cleaves the beta chain of laminin, Thrombosis Research, vol.21, issue.6, pp.663-673, 1981.
DOI : 10.1016/0049-3848(81)90268-1

H. Lijnen, Plasmin and matrix metalloproteinases in vascular remodeling, Thromb Haemost, vol.86, pp.324-333, 2001.

P. Carmeliet, L. Moons, M. Dewerchin, N. Mackman, T. Luther et al., Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System, Annals of the New York Academy of Sciences, vol.13, issue.1 Atheroscleros, pp.191-206, 1997.
DOI : 10.1016/0014-5793(94)01458-D

A. Luttun, F. Lupu, E. Storkebaum, M. Hoylaerts, L. Moons et al., Lack of Plasminogen Activator Inhibitor-1 Promotes Growth and Abnormal Matrix Remodeling of Advanced Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.3, pp.499-505, 2002.
DOI : 10.1161/hq0302.104529

P. Carmeliet, L. Kieckens, L. Schoonjans, B. Ream, A. Van-nuffelen et al., Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization., Journal of Clinical Investigation, vol.92, issue.6, pp.2746-2755, 1993.
DOI : 10.1172/JCI116892

H. Lijnen, B. Van-hoef, V. Beelen, and C. D. , Characterization of the Murine Plasma Fibrinolytic System, European Journal of Biochemistry, vol.4, issue.3, pp.863-871, 1994.
DOI : 10.1016/0268-9499(94)90025-6

H. Lijnen, V. Hoef, B. , and C. D. , Characterization of the murine plasminogen/urokinase-type plasminogen-activator system, European Journal of Biochemistry, vol.265, issue.3, pp.840-848, 1996.
DOI : 10.1016/0268-9499(94)90025-6

T. Battle, J. Arnal, M. Challah, and J. Michel, Selective isolation of rat aortic wall layers and their cell types in culture???Application to converting enzyme activity measurement, Tissue and Cell, vol.26, issue.6, pp.943-955, 1994.
DOI : 10.1016/0040-8166(94)90043-4

A. Giles, Guidelines for the use of animals in biomedical research, Thromb Haemost, vol.58, pp.1078-1084, 1987.

H. Lijnen, K. Okada, O. Matsuo, C. D. Dewerchin, and M. , Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding, Blood, vol.93, pp.2274-2281, 1999.

H. Lijnen, V. Hoef, B. Dewerchin, M. , and C. D. , ??2-Antiplasmin Gene Deficiency in Mice Does Not Affect Neointima Formation After Vascular Injury, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.6, pp.1488-1492, 2000.
DOI : 10.1161/01.ATV.20.6.1488

F. Wimazal, W. Sperr, H. Horny, V. Carroll, B. Binder et al., Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells, American Journal of Hematology, vol.100, issue.1, pp.66-77, 1999.
DOI : 10.1002/(SICI)1096-8652(199905)61:1<66::AID-AJH12>3.0.CO;2-3

K. Chen and T. Wight, Proteoglycans in arterial smooth muscle cell cultures: an ultrastructural histochemical analysis., Journal of Histochemistry & Cytochemistry, vol.32, issue.4, pp.347-357, 1984.
DOI : 10.1177/32.4.6200530

J. Boyle, D. Bowyer, P. Weissberg, and M. Bennett, Human Blood-Derived Macrophages Induce Apoptosis in Human Plaque-Derived Vascular Smooth Muscle Cells by Fas-Ligand/Fas Interactions, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.21, issue.9, pp.1402-1407, 2001.
DOI : 10.1161/hq0901.094279

J. Boyle, P. Weissberg, and M. Bennett, Human Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis Requires NO Enhancement of Fas/Fas-L Interactions, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.10, pp.1624-1630, 2002.
DOI : 10.1161/01.ATV.0000033517.48444.1A

S. Chan, L. Hegyi, S. Scott, N. Cary, P. Weissberg et al., Sensitivity to Fas-Mediated Apoptosis Is Determined Below Receptor Level in Human Vascular Smooth Muscle Cells, Circulation Research, vol.86, issue.10, pp.1038-1046, 2000.
DOI : 10.1161/01.RES.86.10.1038

T. Razzaq, R. Bass, D. Vines, F. Werner, S. Whawell et al., Functional Regulation of Tissue Plasminogen Activator on the Surface of Vascular Smooth Muscle Cells by the Type-II Transmembrane Protein p63 (CKAP4), Journal of Biological Chemistry, vol.278, issue.43, pp.42679-42685, 2003.
DOI : 10.1074/jbc.M305695200

R. Reddick, S. Zhang, and N. Maeda, Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression [published erratum appears in Arterioscler Thromb 1994 May;14(5):839], Arteriosclerosis, Thrombosis, and Vascular Biology, vol.14, issue.1, pp.141-147, 1994.
DOI : 10.1161/01.ATV.14.1.141

Y. Nakashima, A. Plump, E. Raines, J. Breslow, and R. Ross, ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.14, issue.1, pp.133-140, 1994.
DOI : 10.1161/01.ATV.14.1.133

N. Al-fakhri, T. Chavakis, T. Schmidt-woll, B. Huang, S. Cherian et al., Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their antiadhesive properties, Biol Chem, vol.384, pp.423-435, 2003.

H. Kwaan, J. Wang, K. Svoboda, and P. Declerck, Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis, Br J Cancer, vol.82, pp.1702-1708, 2000.

P. Rossignol, B. Ho-tin-noe, R. Vranckx, M. Bouton, O. Meilhac et al., Protease Nexin-1 Inhibits Plasminogen Activation-induced Apoptosis of Adherent Cells, Journal of Biological Chemistry, vol.279, issue.11, pp.10346-10356, 2004.
DOI : 10.1074/jbc.M310964200

G. Davis, P. Allen, K. Salazar, R. Maxwell, and S. , Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices, J Cell Sci, vol.114, pp.917-930, 2001.

J. Martin-ventura, L. Blanco-colio, B. Munoz-garcia, A. Gomez-hernandez, A. Arribas et al., NF-??B Activation and Fas Ligand Overexpression in Blood and Plaques of Patients With Carotid Atherosclerosis: Potential Implication in Plaque Instability, Stroke, vol.35, issue.2, pp.458-463, 2004.
DOI : 10.1161/01.STR.0000114876.51656.7A

X. Zhang, A. Chaudhry, and S. Chintala, Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage, Mol Vis, vol.9, pp.238-248, 2003.

A. Reijerkerk, L. Mosnier, O. Kranenburg, B. Bouma, P. Carmeliet et al., Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system, Mol Cancer Res, vol.1, pp.561-568, 2003.

A. Cozen, H. Moriwaki, M. Kremen, M. Deyoung, H. Dichek et al., Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death, Circulation, vol.109, issue.17, pp.2129-2135, 2004.
DOI : 10.1161/01.CIR.0000127369.24127.03

K. Hishikawa, T. Nakaki, T. Fujii, D. Meyer, G. Muhring et al., Transforming growth factor-beta induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells Apoptosis and related proteins in different stages of human atherosclerotic plaques, Eur J Pharmacol. Kockx MM Circulation, vol.38597, issue.42, pp.287-2902307, 1998.

M. Bennett, G. Evan, and S. Schwartz, Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques., Journal of Clinical Investigation, vol.95, issue.5, pp.2266-2274, 1995.
DOI : 10.1172/JCI117917

E. Lutgens, E. De-muinck, P. Kitslaar, J. Tordoir, H. Wellens et al., Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques, Cardiovascular Research, vol.41, issue.2, pp.473-479, 1999.
DOI : 10.1016/S0008-6363(98)00311-3

I. Bot, V. Der-thusen, J. Donners, M. Lucas, A. Fekkes et al., Serine Protease Inhibitor Serp-1 Strongly Impairs Atherosclerotic Lesion Formation and Induces a Stable Plaque Phenotype in ApoE-/- Mice, Circulation Research, vol.93, issue.5, pp.464-471, 2003.
DOI : 10.1161/01.RES.0000090993.01633.D4